Cormorant Asset Management, Lp Prometheus Biosciences, Inc. (RXDX) insider trading activity

Cormorant Asset Management, LP Transaction History

Date	Transaction	Value	Shares Traded	Form
Mar 16 2021	BUY Open market or private purchase	$7,125,000 $19.0 p/Share	375,000
Mar 16 2021	BUY Conversion of derivative security	-	1,848,022

Also insider at

KZR

Kezar Life Sciences, Inc. Healthcare

> 10% Shareholder

APLS

Apellis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

> 10% Shareholder

AXNX

Axonics, Inc. Healthcare

> 10% Shareholder

TPTX

Turning Point Therapeutics, Inc.

> 10% Shareholder

RNA

Avidity Biosciences, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

AVIR

Atea Pharmaceuticals, Inc. Healthcare

OLMA

Olema Pharmaceuticals, Inc. Healthcare

BCAB

BioAtla, Inc. Healthcare

DSGN

Design Therapeutics, Inc. Healthcare

BMEA

Biomea Fusion, Inc. Healthcare

Director

RAIN

Rain Therapeutics Inc. Healthcare

VERV

Verve Therapeutics, Inc. Healthcare

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

ELEV

Elevation Oncology, Inc. Healthcare

AVTE

Aerovate Therapeutics, Inc. Healthcare

ICVX

Icosavax, Inc. Healthcare

IMRX

Immuneering Corp Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

PYXS

Pyxis Oncology, Inc. Healthcare

VTYX

Ventyx Biosciences, Inc. Healthcare

VIGL

Vigil Neuroscience, Inc. Healthcare

AMAM

Ambrx Biopharma Inc. Healthcare

GRNA

GreenLight Biosciences Holdings, PBC Healthcare

AMAM

Ambrx Biopharma, Inc.

EYPT

EyePoint Pharmaceuticals, Inc. Healthcare

CRBP

Corbus Pharmaceuticals Holdings, Inc. Healthcare

BIOA

BioAge Labs, Inc.

DRUG

BRIGHT MINDS BIOSCIENCES INC. Healthcare

CAM